D - Description
|
Quality
Management |
Training and
Education |
Public
Involvement |
| Description | |
|---|---|
Name |
AEPC Task Force on Clinical (drug) Trials |
| Year of foundation | 2018 |
| Preterm and/or term newborn | Yes |
| Infants from 1 month to less than 24 months of age | Yes |
| Children from 2 years to less than 12 years of age | Yes |
| Adolescents from 12 years to less than 18 years | Yes |
| Paediatric age ranges of study participants covered by the network | 0-18 years |
| Multispeciality? Specify | - |
| Speciality/disease specific? Specify | cardiology |
| Conditions covered? Specify | congenital and acquired heart disease |
| Procedure/Intervention specific? Specify | - |
| Number of collaborating countries | 35 |
| List of collaborating countries | https://www.aepc.org/nationaldelegates -a-i Austria, Azerbaijan, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom |
| Number of collaborating centres | 35 |
| List of collaborating centres | Not provided |
| Type of activity/studies | |
| Clinical Studies | Yes |
| Experimental research | Yes |
| Other activity | training and education |